Skip to content
2000
Volume 6, Issue 1
  • ISSN: 2666-7967
  • E-ISSN: 2666-7975

Abstract

Aim

This study aimed to determine the factors related to hospitalization associated with COVID-19.

Methods

A total of 1000 patients with confirmed COVID-19 by positive PCR test participated in this study. They were randomly selected from positive test patients during this time. They or their first-degree relatives were contacted over the phone and were asked the questions of the checklist regarding socio-demographics and factors related to the period of the COVID-19 pandemic, symptoms of recent infection with COVID-19, and probable factors affecting patients’ hospitalization. Mean and standard deviation were used for describing quantitative variables and frequency (percent) of qualitative variables. Moreover, logistic regression was applied to determine influential factors related to patients’ hospitalization due to COVID-19.

Results

The mean age of the patients was 46.66±17.39, and 53.6% were men. Moreover, 65.6% suffered from chronic diseases. Cough, nausea, chest pain, and fever were the most common symptoms, which were found in more than 50% of patients. It was found that the chances of hospitalization increased with older ages, having more children, addiction of the patient or spouse, job other than health care provider, not regularly using dairy products, not consuming supplements, recent stressful life events, not obeying physical distancing and hospitalization or dead of family members from COVID-19 during patient’s infection.

Conclusion

Age, number of children, self-addiction or spouse addiction, job, dairy products or supplement consumption, encountering stressful life events, social distancing, and status of COVID-19 in family members were found to be influential factors in the hospitalization during infection by COVID-19. People with risk of hospitalization can benefit from modifying their life styles and preventive interventions.

Loading

Article metrics loading...

/content/journals/covid/10.2174/0126667975285430240123092043
2024-02-01
2025-01-06
Loading full text...

Full text loading...

References

  1. World Health Organization. Statement on the Second Meeting of the International Health Regulations (2005) Emergency Committee Regarding the Outbreak of Novel Coronavirus (2019-nCoV).2020Available from: https://www.who.int/news-room/detail/30-01-2020-statement-on-the-second-meeting-of-the-internationalhealth-regulations-(2005)-emergency-committee-regardingthe-outbreak-of-novel-coronavirus-(2019-ncov)
  2. GargS. KimL. WhitakerM. Hospitalization rates and characteristics of patients hospitalized with laboratory-confirmed coronavirus disease 2019—COVID-NET, 14 states, March 1-30, 2020.MMWR Morb. Mortal. Wkly. Rep.2020691545846410.15585/mmwr.mm6915e3 32298251
    [Google Scholar]
  3. BialekS. BoundyE. BowenV. COVID-19 response team. severe outcomes among patients with coronavirus disease 2019 (COVID-19)—United States, February 12-March 16, 2020.MMWR Morb. Mortal. Wkly. Rep.2020691234334610.15585/mmwr.mm6912e2 32214079
    [Google Scholar]
  4. TelleK.E. GrøslandM. HelgelandJ. HåbergS.E. Factors associated with hospitalization, invasive mechanical ventilation treatment and death among all confirmed COVID-19 cases in Norway: Prospective cohort study.Scand. J. Public Health2021491414710.1177/1403494820985172 33461404
    [Google Scholar]
  5. LipsitchM. SwerdlowD.L. FinelliL. Defining the epidemiology of Covid-19—studies needed.N. Engl. J. Med.2020382131194119610.1056/NEJMp2002125 32074416
    [Google Scholar]
  6. GottliebM. SansomS. FrankenbergerC. WardE. HotaB. Clinical course and factors associated with hospitalization and critical illness among COVID‐19 patients in Chicago, Illinois.Acad. Emerg. Med.2020271096397310.1111/acem.14104 32762106
    [Google Scholar]
  7. WuZ. McGooganJ.M. Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in China: Summary of a report of 72 314 cases from the Chinese Center for Disease Control and Prevention.JAMA2020323131239124210.1001/jama.2020.2648 32091533
    [Google Scholar]
  8. GuanW. NiZ. HuY. Clinical characteristics of coronavirus disease 2019 in China.N. Engl. J. Med.2020382181708172010.1056/NEJMoa2002032 32109013
    [Google Scholar]
  9. WangD. HuB. HuC. Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus–infected pneumonia in Wuhan, China.JAMA2020323111061106910.1001/jama.2020.1585 32031570
    [Google Scholar]
  10. Age, Sex, Existing Conditions of COVID-19 Cases and Deaths.Available from: https://www. worldometers. info/coronavirus/coronavirus-age-sex-demographics (Accessed on: April. 2020; 5).
  11. ShammiM. Bodrud-DozaM. Towfiqul IslamA.R.M. RahmanM.M. COVID-19 pandemic, socioeconomic crisis and human stress in resource-limited settings: A case from Bangladesh.Heliyon202065e0406310.1016/j.heliyon.2020.e04063 32462098
    [Google Scholar]
  12. Khalatbari-SoltaniS. CummingR.G. DelpierreC. Kelly-IrvingM. Importance of collecting data on socioeconomic determinants from the early stage of the COVID-19 outbreak onwards.J. Epidemiol. Community Health2020748jech-2020-21429710.1136/jech‑2020‑214297 32385126
    [Google Scholar]
  13. NicolaM. AlsafiZ. SohrabiC. The socio-economic implications of the coronavirus pandemic (COVID-19): A review.Int. J. Surg.20207818519310.1016/j.ijsu.2020.04.018 32305533
    [Google Scholar]
  14. QiuY. ChenX. ShiW. Impacts of social and economic factors on the transmission of coronavirus disease 2019 (COVID-19) in China.J. Popul. Econ.20203341127117210.1007/s00148‑020‑00778‑2 32395017
    [Google Scholar]
  15. YordanovY. DinhA. BleibtreuA. Clinical characteristics and factors associated with hospital admission or death in 43 103 adult outpatients with coronavirus disease 2019 managed with the Covidom telesurveillance solution: A prospective cohort study.Clin. Microbiol. Infect.20212781158116610.1016/j.cmi.2021.04.010 33915287
    [Google Scholar]
  16. FreitesN.D.D. LeonL. MucientesA. Risk factors for hospital admissions related to COVID-19 in patients with autoimmune inflammatory rheumatic diseases.Ann. Rheum. Dis.202079111393139910.1136/annrheumdis‑2020‑217984 32769150
    [Google Scholar]
  17. PetrilliC.M. JonesS.A. YangJ. Factors associated with hospital admission and critical illness among 5279 people with coronavirus disease 2019 in New York City: prospective cohort study.BMJ2020369m196610.1136/bmj.m1966 32444366
    [Google Scholar]
  18. DochertyA.B. HarrisonE.M. GreenC.A. Features of 20 133 UK patients in hospital with covid-19 using the ISARIC WHO clinical characterisation protocol: Prospective observational cohort study.BMJ2020369m198510.1136/bmj.m1985 32444460
    [Google Scholar]
  19. TartofS.Y. QianL. HongV. Obesity and mortality among patients diagnosed with COVID-19: Results from an integrated health care organization.Ann. Intern. Med.20201731077378110.7326/M20‑3742 32783686
    [Google Scholar]
  20. OpalS.M. GirardT.D. ElyE.W. The immunopathogenesis of sepsis in elderly patients.Clin. Infect. Dis.200541S7S504S51210.1086/432007 16237654
    [Google Scholar]
  21. KassD.A. DuggalP. CingolaniO. Obesity could shift severe COVID-19 disease to younger ages.Lancet2020395102361544154510.1016/S0140‑6736(20)31024‑2 32380044
    [Google Scholar]
  22. ZhouF. YuT. DuR. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: A retrospective cohort study.Lancet2020395102291054106210.1016/S0140‑6736(20)30566‑3 32171076
    [Google Scholar]
  23. LiuZ. LongW. TuM. Lymphocyte subset (CD4+, CD8+) counts reflect the severity of infection and predict the clinical outcomes in patients with COVID-19.J. Infect.202081231835610.1016/j.jinf.2020.03.054 32283159
    [Google Scholar]
  24. TerposE. Ntanasis-StathopoulosI. ElalamyI. Hematological findings and complications of COVID ‐19.Am. J. Hematol.202095783484710.1002/ajh.25829 32282949
    [Google Scholar]
  25. HuangC. WangY. LiX. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China.Lancet20203951022349750610.1016/S0140‑6736(20)30183‑5 31986264
    [Google Scholar]
  26. CronR.Q. ChathamW.W. The rheumatologist’s role in COVID-19.J. Rheumatol.202047563964210.3899/jrheum.200334 32209661
    [Google Scholar]
  27. WuS. XueL. Legido-QuigleyH. Understanding factors influencing the length of hospital stay among non-severe COVID-19 patients: A retrospective cohort study in a Fangcang shelter hospital.PLoS One20201510e024095910.1371/journal.pone.0240959 33085709
    [Google Scholar]
  28. GuoA. LuJ. TanH. Risk factors on admission associated with hospital length of stay in patients with COVID-19: A retrospective cohort study.Sci. Rep.2021111731010.1038/s41598‑021‑86853‑4 33790365
    [Google Scholar]
  29. ZhengZ. PengF. XuB. Risk factors of critical & mortal COVID-19 cases: A systematic literature review and meta-analysis.J. Infect.2020812e16e2510.1016/j.jinf.2020.04.021 32335169
    [Google Scholar]
  30. YangJ. ZhengY. GouX. Prevalence of comorbidities and its effects in patients infected with SARS-CoV-2: A systematic review and meta-analysis.Int. J. Infect. Dis.202094919510.1016/j.ijid.2020.03.017 32173574
    [Google Scholar]
  31. KumarA. AroraA. SharmaP. Is diabetes mellitus associated with mortality and severity of COVID-19? A meta-analysis.Diabetes Metab. Syndr.202014453554510.1016/j.dsx.2020.04.044 32408118
    [Google Scholar]
  32. YangJ.K. FengY. YuanM.Y. Plasma glucose levels and diabetes are independent predictors for mortality and morbidity in patients with SARS.Diabet. Med.200623662362810.1111/j.1464‑5491.2006.01861.x 16759303
    [Google Scholar]
  33. YangJ.K. LinS.S. JiX.J. GuoL.M. Binding of SARS coronavirus to its receptor damages islets and causes acute diabetes.Acta Diabetol.201047319319910.1007/s00592‑009‑0109‑4 19333547
    [Google Scholar]
  34. IelapiN. LicastroN. ProvenzanoM. AndreucciM. Cardiovascular disease as a biomarker for an increased risk of COVID-19 infection and related poor prognosis.Biomark Med2020713716
    [Google Scholar]
  35. SsentongoP. SsentongoA.E. HeilbrunnE.S. BaD.M. ChinchilliV.M. Association of cardiovascular disease and 10 other pre-existing comorbidities with COVID-19 mortality: A systematic review and meta-analysis.PLoS One2020158e023821510.1371/journal.pone.0238215 32845926
    [Google Scholar]
  36. LiuY. HäussingerL. SteinackerJ.M. Dinse-LambrachtA. Association between the dynamics of the COVID-19 epidemic and ABO blood type distribution.Epidemiol. Infect.2021149e1910.1017/S0950268821000030 33407977
    [Google Scholar]
  37. MendyA. KellerJ.L. ApewokinS. MorrowA.L. Is blood type associated with COVID-19 severity?medRxiv20202020.0810.1101/2020.08.11.20172676
    [Google Scholar]
  38. ShakoorH. FeehanJ. Al DhaheriA.S. Immune-boosting role of vitamins D, C, E, zinc, selenium and omega-3 fatty acids: Could they help against COVID-19?Maturitas20211431910.1016/j.maturitas.2020.08.003 33308613
    [Google Scholar]
  39. TaghdirM. SepandiM. AbbaszadehS. ParastoueiK. A review on some nutrition-based interventions in COVID-19.J Mil Med202022169176
    [Google Scholar]
  40. SaeediM. Omrani-NavaV. MalekiI. Hedayatizadeh-OmranA. AhmadiA. MoosazadehM. Opium addiction and COVID-19: Truth or false beliefs.Iran. J. Psychiatry. Behav. Sci.20201422020
    [Google Scholar]
  41. RiahiT. Sadeghzadeh-BazarganA. ShokriS. The effect of opium on severity of COVID-19 infection: An original study from Iran.Med. J. Islam. Repub. Iran20213511510.47176/mjiri.35.115 34956961
    [Google Scholar]
  42. Dolati-SomarinA. BaharehA-N. The reasons for higher mortality rate in opium addicted patients with COVID-19: A narrative review.Iran. J. Public Health20215047010.18502/ijph.v50i3.5587
    [Google Scholar]
  43. Abboah-OffeiM. SalifuY. AdewaleB. BayuoJ. Ofosu-PokuR. Opare-LokkoE.B.A. A rapid review of the use of face mask in preventing the spread of COVID-19.IJNS Adv2021310001310.1016/j.ijnsa.2020.100013
    [Google Scholar]
  44. ChaabnaK. DoraiswamyS. MamtaniR. CheemaS. Facemask use in community settings to prevent respiratory infection transmission: A rapid review and meta-analysis.Int. J. Infect. Dis.202110419820610.1016/j.ijid.2020.09.1434 32987183
    [Google Scholar]
  45. TalicS. ShahS. WildH. Effectiveness of public health measures in reducing the incidence of COVID-19, SARS-CoV-2 transmission, and COVID-19 mortality: Systematic review and meta-analysis.BMJ2021375e06830210.1136/bmj‑2021‑068302 34789505
    [Google Scholar]
  46. CocliteD. NapoletanoA. GianolaS. Face mask use in the community for reducing the spread of COVID-19: A systematic review.Front. Med.2021759426910.3389/fmed.2020.594269 33511141
    [Google Scholar]
  47. MostafaeiA. HajebrahimiS. Sadeghi-ghyassiF. Can wearing a face mask protect from COVID-19? A systematic review.Iran. J. Med. Microbiol.202014210110710.30699/ijmm.14.2.101
    [Google Scholar]
  48. QianM. JiangJ. COVID-19 and social distancing.Iran. J. Public Health202013 32837835
    [Google Scholar]
  49. ZhongB.L. LuoW. LiH.M. Knowledge, attitudes, and practices towards COVID-19 among Chinese residents during the rapid rise period of the COVID-19 outbreak: A quick online cross-sectional survey.Int. J. Biol. Sci.202016101745175210.7150/ijbs.45221 32226294
    [Google Scholar]
  50. AlobuiaW.M. Dalva-BairdN.P. ForresterJ.D. BendavidE. BhattacharyaJ. KebebewE. Racial disparities in knowledge, attitudes and practices related to COVID-19 in the USA.J Public Health202042347047810.1093/pubmed/fdaa069 32490519
    [Google Scholar]
/content/journals/covid/10.2174/0126667975285430240123092043
Loading
/content/journals/covid/10.2174/0126667975285430240123092043
Loading

Data & Media loading...

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test